VTGN compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

VTGNVistagen Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

VTGNVistagen Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

VTGNVistagen Therapeutics, Inc.

0.17▼−7.81%

Mkt cap$8.2MRevenue$1MQ1 FY27Revenue$1MFY26

LLYELI Lilly & Co

1,387.36▼−2.16%

Regular sessionNov 5 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 5 '26

VTGNVistagen Therapeutics, Inc.

LLYELI Lilly & Co

0.17▼−7.81%

Price

1,387.36▼−2.16%

$8.2M

Mkt cap

$1.3T

Q1 FY27$1M

Revenue

$24.4BQ3 FY26

FY26$1M

Revenue

$65.2BFY25

VTGN0.17▼−7.81%vsLLY1,387.36▼−2.16%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

VTGN: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VTGN 4

—Pherin Pharmaceuticals, Inc. (Pherin)unlistedsupplier

—AffaMedunlistedcustomer

—AffaMed Therapeuticsunlistedcustomer

—Fuji Pharmaunlistedcustomer

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

VTGN, solidLLY, dashed